People in the News | GenomeWeb

People in the News

Premium

David Macdonald has been named CEO at Agendia. He replaces Bernhard Sixt, who led the Dutch diagnostics firm since its founding in 2003. Sixt will remain with Agendia in an "advisory capacity," Agendia said.

Macdonald has served as Agendia's chief operating officer since last year. He previously worked at Quest Diagnostics, Behring Diagnostics, and Novo Medical. Macdonald holds a BS in management and finance from Northeastern University and an MBA from Babson College.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.